Preventive Medicine and Public Health Microbiology
Preventive medicine aims to stop disease before it starts through screening, vaccination, counselling and healthy environments. Public health microbiology supports this work by detecting and tracking harmful microbes.
The Preventive Medicine and Public Health Microbiology session at GCPE 2027 covers prevention and laboratory public health. It connects closely with vaccines, immunization and prevention strategies, a core part of prevention.
Preventive medicine focuses on keeping people healthy rather than treating illness. Screening, vaccination and lifestyle advice are key tools. Public health laboratories detect and track harmful microbes. Their work protects food, water and communities.
Key Topics in Preventive Medicine and Public Health Microbiology
• Screening and early detection
• Clinical preventive services
• Public health laboratories
• Food and water microbiology
• Antimicrobial resistance surveillance
• Hospital and community infection prevention
• Microbiome and health
• Laboratory diagnostics for public health
• Prevention in primary care
• Biosafety and biosecurity
Recent Advances in Preventive Medicine and Public Health Microbiology
Public health laboratories are using genomic and rapid testing to detect infections faster, supporting infectious diseases and outbreak management. Antimicrobial resistance surveillance links human, animal and environmental testing, a theme in one health and environmental integration.
Preventive care in general practice, discussed in primary healthcare and community interventions, remains essential.
Rapid testing is helping laboratories respond faster to threats. Screening programmes are being refined to target those most at risk. Antimicrobial resistance monitoring is expanding. Laboratory networks are sharing data across borders.
Who Should Attend the Preventive Medicine and Public Health Microbiology Session
• Preventive medicine physicians
• Public health microbiologists
• Laboratory scientists
• Infection prevention specialists
• PhD students and early-career researchers
• Food and water safety professionals
Why Present Your Research in Preventive Medicine and Public Health Microbiology
Presenting at GCPE 2027 lets you share prevention and laboratory research with an international audience. You can connect with colleagues in HIV/AIDS, tuberculosis and sexually transmitted infections using lab testing to guide control. Prevention and laboratory work are closely linked. Presenting here helps strengthen this connection.
Frequently Asked Questions
Can laboratory scientists present?
Yes. Laboratory and microbiology research is welcome.
Does this session cover food safety?
Yes. Food and water microbiology are key topics.
Where is GCPE 2027 held?
GCPE 2027 is held at Delta Hotels Heathrow Windsor, London, UK, from 17 to 19 May 2027, with online participation.
HIV/AIDS, Tuberculosis and Sexually Transmitted Infections
• SEO title: HIV/AIDS, TB and STIs | GCPE 2027
• Meta description: Share research on HIV, tuberculosis and sexually transmitted infections at GCPE 2027, London, 17–19 May 2027. Submit your abstract today.
• Meta keywords: HIV, AIDS, tuberculosis, TB control, sexually transmitted infections, PrEP, drug-resistant TB, GCPE 2027, public health conference London
About HIV/AIDS, Tuberculosis and Sexually Transmitted Infections
HIV, tuberculosis (TB) and sexually transmitted infections (STIs) remain major public health challenges. Many affect the same communities and need joined-up prevention, testing and treatment.
The HIV/AIDS, Tuberculosis and Sexually Transmitted Infections session at GCPE 2027 covers research on these infections. It links closely with infectious diseases and outbreak management, which looks at infection control more broadly.
HIV, TB and STIs still affect millions of people worldwide. Many cases go undiagnosed, allowing infections to spread. Effective prevention and treatment exist but do not reach everyone. Stigma remains a major barrier to care.
Key Topics in HIV/AIDS, Tuberculosis and Sexually Transmitted Infections
• HIV prevention and PrEP
• HIV testing and treatment
• TB detection and treatment
• Drug-resistant TB
• TB and HIV co-infection
• Syphilis and congenital syphilis
• Gonorrhoea and antimicrobial resistance
• Stigma and access to services
• Key and vulnerable populations
• Global targets and elimination
Recent Advances in HIV/AIDS, Tuberculosis and Sexually Transmitted Infections
Long-acting PrEP and treatment are making HIV prevention easier. New shorter TB treatments are improving cure rates, and better tests from preventive medicine and public health microbiology are finding more cases.
Rising syphilis rates are a concern in many countries, linked with women’s and reproductive health. Reducing stigma is central, a theme in health equity and social determinants of health.
New prevention tools are reducing HIV infections. Shorter TB treatments are making cure easier to achieve. Testing services are reaching more people through community and self-testing. Global targets are driving progress towards elimination.
Who Should Attend the HIV/AIDS, Tuberculosis and Sexually Transmitted Infections Session
• HIV, TB and sexual health clinicians
• Public health practitioners
• Epidemiologists
• Community organisations
• PhD students and early-career researchers
• Programme managers
Why Present Your Research in HIV/AIDS, Tuberculosis and Sexually Transmitted Infections
Presenting at GCPE 2027 lets you share research with an international audience. You can connect with colleagues in global health and international healthcare systems working on global elimination targets. These infections need coordinated action. Your work can help programmes reach global goals.
Frequently Asked Questions
Can I present PrEP programme data?
Yes. HIV prevention programmes are welcome.
Does this session cover drug-resistant TB?
Yes. Drug-resistant TB is a key topic.
When and where is GCPE 2027?
GCPE 2027 takes place from 17 to 19 May 2027 at Delta Hotels Heathrow Windsor, London, UK, and online.